Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 99

1.

Investigation of quantum and thermal fluctuations ferromagnetic spin chains with easy-plane anisotropy.

Wieser R.

J Phys Condens Matter. 2019 Aug 14;31(32):325801. doi: 10.1088/1361-648X/ab1f3b. Epub 2019 May 3.

PMID:
31051487
2.

Molecular and genetic alterations associated with therapy resistance and relapse of acute myeloid leukemia.

Hackl H, Astanina K, Wieser R.

J Hematol Oncol. 2017 Feb 20;10(1):51. doi: 10.1186/s13045-017-0416-0. Review.

3.

Self-consistent mean field theory studies of the thermodynamics and quantum spin dynamics of magnetic Skyrmions.

Wieser R.

J Phys Condens Matter. 2017 May 4;29(17):175803. doi: 10.1088/1361-648X/aa5f4e. Epub 2017 Feb 8.

PMID:
28177926
4.

Derivation of a time dependent Schrödinger equation as the quantum mechanical Landau-Lifshitz-Bloch equation.

Wieser R.

J Phys Condens Matter. 2016 Oct 5;28(39):396003. doi: 10.1088/0953-8984/28/39/396003. Epub 2016 Aug 5.

PMID:
27494599
5.

Increased Expression of miR-23a Mediates a Loss of Expression in the RAF Kinase Inhibitor Protein RKIP.

Hatzl S, Geiger O, Kuepper MK, Caraffini V, Seime T, Furlan T, Nussbaumer E, Wieser R, Pichler M, Scheideler M, Nowek K, Jongen-Lavrencic M, Quehenberger F, Wölfler A, Troppmair J, Sill H, Zebisch A.

Cancer Res. 2016 Jun 15;76(12):3644-54. doi: 10.1158/0008-5472.CAN-15-3049. Epub 2016 Apr 15.

6.

EVI1 promotes tumor growth via transcriptional repression of MS4A3.

Heller G, Rommer A, Steinleitner K, Etzler J, Hackl H, Heffeter P, Tomasich E, Filipits M, Steinmetz B, Topakian T, Klingenbrunner S, Ziegler B, Spittler A, Zöchbauer-Müller S, Berger W, Wieser R.

J Hematol Oncol. 2015 Mar 21;8:28. doi: 10.1186/s13045-015-0124-6.

7.

Induction of the proapoptotic tumor suppressor gene Cell Adhesion Molecule 1 by chemotherapeutic agents is repressed in therapy resistant acute myeloid leukemia.

Fisser MC, Rommer A, Steinleitner K, Heller G, Herbst F, Wiese M, Glimm H, Sill H, Wieser R.

Mol Carcinog. 2015 Dec;54(12):1815-9. doi: 10.1002/mc.22252. Epub 2014 Dec 9.

PMID:
25491945
8.

The oncogene EVI1 enhances transcriptional and biological responses of human myeloid cells to all-trans retinoic acid.

Steinmetz B, Hackl H, Slabáková E, Schwarzinger I, Smějová M, Spittler A, Arbesu I, Shehata M, Souček K, Wieser R.

Cell Cycle. 2014;13(18):2931-43. doi: 10.4161/15384101.2014.946869. Erratum in: Cell Cycle. 2015;14(11):1759.

9.

A gene expression profile associated with relapse of cytogenetically normal acute myeloid leukemia is enriched for leukemia stem cell genes.

Hackl H, Steinleitner K, Lind K, Hofer S, Tosic N, Pavlovic S, Suvajdzic N, Sill H, Wieser R.

Leuk Lymphoma. 2015 Apr;56(4):1126-8. doi: 10.3109/10428194.2014.944523. Epub 2014 Aug 18. No abstract available.

10.

A survey of "mental hardiness" and "mental toughness" in professional male football players.

Wieser R, Thiel H.

Chiropr Man Therap. 2014 Apr 15;22:17. doi: 10.1186/2045-709X-22-17. eCollection 2014.

11.

Overexpression of primary microRNA 221/222 in acute myeloid leukemia.

Rommer A, Steinleitner K, Hackl H, Schneckenleithner C, Engelmann M, Scheideler M, Vlatkovic I, Kralovics R, Cerny-Reiterer S, Valent P, Sill H, Wieser R.

BMC Cancer. 2013 Jul 29;13:364. doi: 10.1186/1471-2407-13-364.

12.

Comparison of quantum and classical relaxation in spin dynamics.

Wieser R.

Phys Rev Lett. 2013 Apr 5;110(14):147201. Epub 2013 Apr 2.

PMID:
25167028
13.

EVI1 inhibits apoptosis induced by antileukemic drugs via upregulation of CDKN1A/p21/WAF in human myeloid cells.

Rommer A, Steinmetz B, Herbst F, Hackl H, Heffeter P, Heilos D, Filipits M, Steinleitner K, Hemmati S, Herbacek I, Schwarzinger I, Hartl K, Rondou P, Glimm H, Karakaya K, Krämer A, Berger W, Wieser R.

PLoS One. 2013;8(2):e56308. doi: 10.1371/journal.pone.0056308. Epub 2013 Feb 14.

14.

EVI1 and MDS1/EVI1 expression during primary human hematopoietic progenitor cell differentiation into various myeloid lineages.

Steinleitner K, Rampetsreiter P, Köffel R, Ramanathan G, Mannhalter C, Strobl H, Wieser R.

Anticancer Res. 2012 Nov;32(11):4883-9.

15.

New functions for ecotropic viral integration site 1 (EVI1), an oncogene causing aggressive malignant disease.

Wieser R.

Cell Cycle. 2012 Nov 1;11(21):3915. doi: 10.4161/cc.22392. Epub 2012 Oct 3. No abstract available.

16.

Information transfer by vector spin chirality in finite magnetic chains.

Menzel M, Mokrousov Y, Wieser R, Bickel JE, Vedmedenko E, Blügel S, Heinze S, von Bergmann K, Kubetzka A, Wiesendanger R.

Phys Rev Lett. 2012 May 11;108(19):197204. Epub 2012 May 7.

PMID:
23003082
17.

Clinical significance of genetic aberrations in secondary acute myeloid leukemia.

Milosevic JD, Puda A, Malcovati L, Berg T, Hofbauer M, Stukalov A, Klampfl T, Harutyunyan AS, Gisslinger H, Gisslinger B, Burjanivova T, Rumi E, Pietra D, Elena C, Vannucchi AM, Doubek M, Dvorakova D, Robesova B, Wieser R, Koller E, Suvajdzic N, Tomin D, Tosic N, Colinge J, Racil Z, Steurer M, Pavlovic S, Cazzola M, Kralovics R.

Am J Hematol. 2012 Nov;87(11):1010-6. doi: 10.1002/ajh.23309. Epub 2012 Aug 7.

18.

Domain wall manipulation with a magnetic tip.

Stapelfeldt T, Wieser R, Vedmedenko EY, Wiesendanger R.

Phys Rev Lett. 2011 Jul 8;107(2):027203. Epub 2011 Jul 7.

PMID:
21797636
19.

EVI1-mediated down regulation of MIR449A is essential for the survival of EVI1 positive leukaemic cells.

De Weer A, Van der Meulen J, Rondou P, Taghon T, Konrad TA, De Preter K, Mestdagh P, Van Maerken T, Van Roy N, Jeison M, Yaniv I, Cauwelier B, Noens L, Poirel HA, Vandenberghe P, Lambert F, De Paepe A, Sánchez MG, Odero M, Verhasselt B, Philippé J, Vandesompele J, Wieser R, Dastugue N, Van Vlierberghe P, Poppe B, Speleman F.

Br J Haematol. 2011 Aug;154(3):337-48. doi: 10.1111/j.1365-2141.2011.08737.x. Epub 2011 May 14.

PMID:
21569010
20.

Indirect control of antiferromagnetic domain walls with spin current.

Wieser R, Vedmedenko EY, Wiesendanger R.

Phys Rev Lett. 2011 Feb 11;106(6):067204. Epub 2011 Feb 11. Erratum in: Phys Rev Lett. 2011 Jun 10;106(23):239901.

PMID:
21405493
21.

Tetracycline regulator expression alters the transcriptional program of mammalian cells.

Hackl H, Rommer A, Konrad TA, Nassimbeni C, Wieser R.

PLoS One. 2010 Sep 24;5(9):e13013. doi: 10.1371/journal.pone.0013013.

22.

microRNAs in acute myeloid leukemia: expression patterns, correlations with genetic and clinical parameters, and prognostic significance.

Wieser R, Scheideler M, Hackl H, Engelmann M, Schneckenleithner C, Hiden K, Papak C, Trajanoski Z, Sill H, Fonatsch C.

Genes Chromosomes Cancer. 2010 Mar;49(3):193-203. doi: 10.1002/gcc.20740. Review.

PMID:
20013895
23.

Zinc finger transcription factor ecotropic viral integration site 1 is induced by all-trans retinoic acid (ATRA) and acts as a dual modulator of the ATRA response.

Bingemann SC, Konrad TA, Wieser R.

FEBS J. 2009 Nov;276(22):6810-22. doi: 10.1111/j.1742-4658.2009.07398.x. Epub 2009 Oct 16.

24.

Inducible expression of EVI1 in human myeloid cells causes phenotypes consistent with its role in myelodysplastic syndromes.

Konrad TA, Karger A, Hackl H, Schwarzinger I, Herbacek I, Wieser R.

J Leukoc Biol. 2009 Oct;86(4):813-22. doi: 10.1189/jlb.0109042. Epub 2009 Jul 15.

25.

Update on genetic and molecular markers associated with myelodysplastic syndromes.

Valent P, Wieser R.

Leuk Lymphoma. 2009 Mar;50(3):341-8. doi: 10.1080/10428190902756107. Review.

PMID:
19263296
26.

Quantized spin waves in antiferromagnetic Heisenberg chains.

Wieser R, Vedmedenko EY, Wiesendanger R.

Phys Rev Lett. 2008 Oct 24;101(17):177202. Epub 2008 Oct 21.

PMID:
18999780
27.

Expression and prognostic significance of different mRNA 5'-end variants of the oncogene EVI1 in 266 patients with de novo AML: EVI1 and MDS1/EVI1 overexpression both predict short remission duration.

Haas K, Kundi M, Sperr WR, Esterbauer H, Ludwig WD, Ratei R, Koller E, Gruener H, Sauerland C, Fonatsch C, Valent P, Wieser R.

Genes Chromosomes Cancer. 2008 Apr;47(4):288-98. doi: 10.1002/gcc.20532.

PMID:
18181178
28.

The oncogene and developmental regulator EVI1: expression, biochemical properties, and biological functions.

Wieser R.

Gene. 2007 Jul 15;396(2):346-57. Epub 2007 Apr 20. Review.

PMID:
17507183
29.

Bortezomib in relapsed multiple myeloma: response rates and duration of response are independent of a chromosome 13q-deletion.

Sagaster V, Ludwig H, Kaufmann H, Odelga V, Zojer N, Ackermann J, Küenburg E, Wieser R, Zielinski C, Drach J.

Leukemia. 2007 Jan;21(1):164-8. Epub 2006 Nov 9.

PMID:
17096015
30.

[Cystic fibrosis--the most frequent life-shortening autosomal recessive disease].

Wieser R.

Wien Med Wochenschr. 2005 Jun;155(11-12):268-72. German.

PMID:
16035387
31.

Regulation of the expression of the oncogene EVI1 through the use of alternative mRNA 5'-ends.

Aytekin M, Vinatzer U, Musteanu M, Raynaud S, Wieser R.

Gene. 2005 Aug 15;356:160-8.

PMID:
16014322
32.

Novel rearrangement of chromosome band 22q11.2 causing 22q11 microdeletion syndrome-like phenotype and rhabdoid tumor of the kidney.

Wieser R, Fritz B, Ullmann R, Müller I, Galhuber M, Storlazzi CT, Ramaswamy A, Christiansen H, Shimizu N, Rehder H.

Hum Mutat. 2005 Aug;26(2):78-83.

PMID:
15957176
33.

Transition to linear domain walls in nanoconstrictions.

Kazantseva N, Wieser R, Nowak U.

Phys Rev Lett. 2005 Jan 28;94(3):037206. Epub 2005 Jan 27.

PMID:
15698319
34.

Disruption of exonic splicing enhancer elements is the principal cause of exon skipping associated with seven nonsense or missense alleles of NF1.

Zatkova A, Messiaen L, Vandenbroucke I, Wieser R, Fonatsch C, Krainer AR, Wimmer K.

Hum Mutat. 2004 Dec;24(6):491-501.

PMID:
15523642
35.

Both IGH translocations and chromosome 13q deletions are early events in monoclonal gammopathy of undetermined significance and do not evolve during transition to multiple myeloma.

Kaufmann H, Ackermann J, Baldia C, Nösslinger T, Wieser R, Seidl S, Sagaster V, Gisslinger H, Jäger U, Pfeilstöcker M, Zielinski C, Drach J.

Leukemia. 2004 Nov;18(11):1879-82.

PMID:
15385925
36.

inv(3)(q21q26) in AML/MDS: Monitoring of the malignant clone with interphase FISH.

Schmidt HH, Pirc-Danoewinata H, Linkesch W, Strunk D, Wieser R.

Haematologica. 2003 Dec;88(12):ECR38. No abstract available.

37.
38.

Interphase fluorescence in situ hybridization assay for the detection of rearrangements of the EVI-1 locus in chromosome band 3q26 in myeloid malignancies.

Wieser R, Schreiner U, Rieder H, Pirc-Danoewinata H, Grüner H, Loncarevic IF, Fonatsch C.

Haematologica. 2003 Jan;88(1):25-30.

39.

Quantitative comparison of the expression of EVI1 and its presumptive antagonist, MDS1/EVI1, in patients with myeloid leukemia.

Vinatzer U, Mannhalter C, Mitterbauer M, Gruener H, Greinix H, Schmidt HH, Fonatsch C, Wieser R.

Genes Chromosomes Cancer. 2003 Jan;36(1):80-9.

PMID:
12461752
40.

Induction of cell differentiation in transformed keratinocytes by synthetic (Glyco)peptides from the homophilic recognition domain of E-cadherin.

Habermann J, Stüber K, Skripko T, Reipen T, Wieser R, Kunz H.

Angew Chem Int Ed Engl. 2002 Nov 15;41(22):4249-52. No abstract available.

PMID:
12434353
41.

Rearrangements of chromosome band 3q21 in myeloid leukemia.

Wieser R.

Leuk Lymphoma. 2002 Jan;43(1):59-65. Review.

PMID:
11908737
42.

Interphase fluorescence in situ hybridization assay for the detection of 3q21 rearrangements in myeloid malignancies.

Wieser R, Schreiner U, Pirc-Danoewinata H, Aytekin M, Schmidt HH, Rieder H, Fonatsch C.

Genes Chromosomes Cancer. 2001 Dec;32(4):373-80.

PMID:
11746978
43.

The leukaemia-associated transcription factors EVI-1 and MDS1/EVI1 repress transcription and interact with histone deacetylase.

Vinatzer U, Taplick J, Seiser C, Fonatsch C, Wieser R.

Br J Haematol. 2001 Sep;114(3):566-73.

PMID:
11552981
44.

Involvement of protein kinase Cdelta in contact-dependent inhibition of growth in human and murine fibroblasts.

Heit I, Wieser RJ, Herget T, Faust D, Borchert-Stuhlträger M, Oesch F, Dietrich C.

Oncogene. 2001 Aug 23;20(37):5143-54.

45.

cDNA cloning, chromosome assignment, and genomic structure of a human gene encoding a novel member of the RBM family.

Stover C, Gradl G, Jentsch I, Speicher MR, Wieser R, Schwaeble W.

Cytogenet Cell Genet. 2001;92(3-4):225-30.

PMID:
11435693
46.

Rottlerin induces a transformed phenotype in human keratinocytes.

Dietrich C, Gumpert N, Heit I, Borchert-Stuhlträger M, Oesch F, Wieser R.

Biochem Biophys Res Commun. 2001 Mar 30;282(2):575-9.

PMID:
11401499
47.

Embryonic lethality and fetal liver apoptosis in mice lacking the c-raf-1 gene.

Mikula M, Schreiber M, Husak Z, Kucerova L, Rüth J, Wieser R, Zatloukal K, Beug H, Wagner EF, Baccarini M.

EMBO J. 2001 Apr 17;20(8):1952-62.

48.

Masked inv(3)(q21q26) in a patient with minimally differentiated acute myeloid leukemia.

Wieser R, Schreiner U, Wollenberg B, Neubauer A, Fonatsch C, Rieder H.

Haematologica. 2001 Feb;86(2):214-5. No abstract available.

49.

The transforming growth factor-beta signaling pathway in tumorigenesis.

Wieser R.

Curr Opin Oncol. 2001 Jan;13(1):70-7. Review.

PMID:
11148690
50.

Mapping of leukaemia-associated breakpoints in chromosome band 3q21 using a newly established PAC contig.

Wieser R, Volz A, Schnittger S, Jäger U, Grüner H, Meran JG, Wimmer K, Ziegler A, Fonatsch C.

Br J Haematol. 2000 Aug;110(2):343-50.

PMID:
10971391

Supplemental Content

Loading ...
Support Center